Indeed, CEACAM6 is part of a family that includes members which are used routinely in clinical pathology to assess tumor specimens and inform disease prognosis and treatment.67–69 CEACAM6 itself is deemed of potential value as a prognosis marker in different types of cancers.33,34,38,40,41 Notably, measuring blood CEACAM6 transcript abundance is considered of potential value for the early detection of colorectal cancer.14–16. Here, CEACAM6 is linked to neoplasm.